I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| microglial cell | 7 studies | 28% ± 8% | |
| macrophage | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 7 studies | 28% ± 8% | |
| macrophage | 3 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of LPAR5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 80% | 489.51 | 287 / 359 | 96% | 25.71 | 274 / 286 |
| thymus | 72% | 232.39 | 470 / 653 | 92% | 66.80 | 555 / 605 |
| intestine | 63% | 722.46 | 613 / 966 | 99% | 28.80 | 523 / 527 |
| brain | 68% | 249.05 | 1809 / 2642 | 93% | 24.60 | 659 / 705 |
| esophagus | 59% | 950.95 | 856 / 1445 | 98% | 25.97 | 180 / 183 |
| bladder | 62% | 255.19 | 13 / 21 | 95% | 20.43 | 478 / 504 |
| lung | 63% | 147.41 | 364 / 578 | 83% | 13.54 | 962 / 1155 |
| skin | 72% | 606.41 | 1305 / 1809 | 53% | 5.23 | 248 / 472 |
| breast | 43% | 84.29 | 199 / 459 | 79% | 7.93 | 885 / 1118 |
| kidney | 30% | 70.03 | 27 / 89 | 70% | 7.90 | 634 / 901 |
| pancreas | 7% | 11.66 | 23 / 328 | 93% | 19.17 | 166 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 26.48 | 29 / 29 |
| spleen | 100% | 1239.26 | 240 / 241 | 0% | 0 | 0 / 0 |
| uterus | 18% | 55.19 | 31 / 170 | 80% | 15.14 | 367 / 459 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 17.80 | 43 / 45 |
| ovary | 14% | 21.61 | 26 / 180 | 79% | 9.17 | 339 / 430 |
| adrenal gland | 81% | 228.41 | 208 / 258 | 13% | 0.88 | 29 / 230 |
| peripheral blood | 91% | 528.97 | 842 / 929 | 0% | 0 | 0 / 0 |
| prostate | 61% | 126.69 | 150 / 245 | 8% | 0.48 | 40 / 502 |
| adipose | 64% | 180.34 | 768 / 1204 | 0% | 0 | 0 / 0 |
| heart | 57% | 202.96 | 494 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 42% | 101.39 | 564 / 1335 | 0% | 0 | 0 / 0 |
| liver | 12% | 18.30 | 26 / 226 | 9% | 0.99 | 35 / 406 |
| eye | 0% | 0 | 0 / 0 | 13% | 0.79 | 10 / 80 |
| muscle | 0% | 0.52 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0032793 | Biological process | positive regulation of CREB transcription factor activity |
| GO_0048266 | Biological process | behavioral response to pain |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0008150 | Biological process | biological_process |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | LPAR5 |
| Protein name | G protein-coupled receptor 92, isoform CRA_a (G-protein coupled receptor) (Lysophosphatidic acid receptor 5) (cDNA, FLJ93614, Homo sapiens G protein-coupled receptor 92 (GPR92), mRNA) Lysophosphatidic acid receptor 5 (LPA receptor 5) (LPA-5) (G-protein coupled receptor 92) (G-protein coupled receptor 93) |
| Synonyms | GPR93 hCG_2039707 GPR92 KPG_010 |
| Description | FUNCTION: Receptor for lysophosphatidic acid (LPA), a mediator of diverse cellular activities. |
| Accessions | Q5KU18 ENST00000431922.1 Q9H1C0 ENST00000329858.9 |
